Antibodies to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in patients with multiple myeloma

Journal of Infectious Diseases

Volumn 178, Issue 3, 1998, Pages 846-849

  Gao, Shou Jiang ^a   Alsina, Melissa ^b   Deng, Jian Hong ^b   Harrison, Chantal R ^b   Montalvo, Eduardo A ^b   Leach, Charles T ^b   David Roodman, G ^b   Jenson, Hal B ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; VIRUS ANTIBODY; VIRUS CAPSID ANTIGEN;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; HUMAN TISSUE; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 0031682695     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515340     Document Type: Article

References (15)

1. Gao SJ, Kingsley L, Hoover DR, et al. Seroconversion of antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996; 335:233-41.
2. Kedes DH, Operskalski E, Busche M, Flood J, Kohn R, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups for sexual transmission. Nature Med 1996; 2:918-24.
3. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians, and Ugandans with and without Kaposi's sarcoma. Nature Med 1996; 2:925-8.
4. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma-associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 348:1133-8.
5. Lennette ET, Blackboume DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996;348:858-61.
6. Lin SF, Sun R, Heston L, et al. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen. J Virol 1997;71:3069-76.
7. Rettig MB, Ma HJ, Vescio RA, et al. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 1997; 276:1851-4.
8. Said JW, Rettig MR, Heppner K, et al. Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. Blood 1997;90:4278-82.
9. Brousset P, Meggetto F, Attal M, Delsol G. Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science 1997; 278:1972-3.
10. Masood R, Zheng T, Tupule A, et al. Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science 1997;278:1970-1.
11. Tarte K, Olsen SJ, Lu ZY, et al. Clinical-grade functional dendritic cells from patients with multiple myeloma are not infected with Kaposi's sarcoma-associated herpesvirus. Blood 1998;91:1852-7.
12. Marcelin AG, Dupin N, Bouscary D, et al. HHV-8 and multiple myeloma in France. Lancet 1997;350:1144.
13. MacKenzie J, Sheldon J, Morgan G, Cook G, Schulz TF, Jarrett RF. HHV-8 and multiple myeloma in the UK. Lancet 1997;350:1144-5.
14. Parravicini C, Lauri E, Baldini L, et al. Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science 1997;278:1969-70.
15. Whitby D, Boshoff C, Luppi M, Torelli G. Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science 1997;278:1971-2.